Historical Valuation
HealthStream Inc (HSTM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.17 is considered Undervalued compared with the five-year average of 15.81. The fair price of HealthStream Inc (HSTM) is between 24.92 to 30.69 according to relative valuation methord. Compared to the current price of 22.10 USD , HealthStream Inc is Undervalued By 11.31%.
Relative Value
Fair Zone
24.92-30.69
Current Price：22.10
11.31%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
HealthStream Inc (HSTM) has a current Price-to-Book (P/B) ratio of 1.94. Compared to its 3-year average P/B ratio of 2.36 , the current P/B ratio is approximately -18.06% higher. Relative to its 5-year average P/B ratio of 2.32, the current P/B ratio is about -16.62% higher. HealthStream Inc (HSTM) has a Forward Free Cash Flow (FCF) yield of approximately 8.52%. Compared to its 3-year average FCF yield of 7.00%, the current FCF yield is approximately 21.78% lower. Relative to its 5-year average FCF yield of 6.44% , the current FCF yield is about 32.24% lower.
P/B
Median3y
2.36
Median5y
2.32
FCF Yield
Median3y
7.00
Median5y
6.44
Competitors Valuation Multiple
AI Analysis for HSTM
The average P/S ratio for HSTM competitors is 2.19, providing a benchmark for relative valuation. HealthStream Inc Corp (HSTM.O) exhibits a P/S ratio of 2.17, which is -0.79% above the industry average. Given its robust revenue growth of 4.62%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HSTM
1Y
3Y
5Y
Market capitalization of HSTM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HSTM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HSTM currently overvalued or undervalued?
HealthStream Inc (HSTM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.17 is considered Undervalued compared with the five-year average of 15.81. The fair price of HealthStream Inc (HSTM) is between 24.92 to 30.69 according to relative valuation methord. Compared to the current price of 22.10 USD , HealthStream Inc is Undervalued By 11.31% .
What is HealthStream Inc (HSTM) fair value?
HSTM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of HealthStream Inc (HSTM) is between 24.92 to 30.69 according to relative valuation methord.
How does HSTM's valuation metrics compare to the industry average?
The average P/S ratio for HSTM's competitors is 2.19, providing a benchmark for relative valuation. HealthStream Inc Corp (HSTM) exhibits a P/S ratio of 2.17, which is -0.79% above the industry average. Given its robust revenue growth of 4.62%, this premium appears unsustainable.
What is the current P/B ratio for HealthStream Inc (HSTM) as of Jan 10 2026?
As of Jan 10 2026, HealthStream Inc (HSTM) has a P/B ratio of 1.94. This indicates that the market values HSTM at 1.94 times its book value.
What is the current FCF Yield for HealthStream Inc (HSTM) as of Jan 10 2026?
As of Jan 10 2026, HealthStream Inc (HSTM) has a FCF Yield of 8.52%. This means that for every dollar of HealthStream Inc’s market capitalization, the company generates 8.52 cents in free cash flow.
What is the current Forward P/E ratio for HealthStream Inc (HSTM) as of Jan 10 2026?
As of Jan 10 2026, HealthStream Inc (HSTM) has a Forward P/E ratio of 26.35. This means the market is willing to pay $26.35 for every dollar of HealthStream Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for HealthStream Inc (HSTM) as of Jan 10 2026?
As of Jan 10 2026, HealthStream Inc (HSTM) has a Forward P/S ratio of 2.17. This means the market is valuing HSTM at $2.17 for every dollar of expected revenue over the next 12 months.